Biosimilar and Interchangeable Biosimilar Products: Considerations for Container Closure Systems and Device Constituent Parts
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 31, 2026
July 31, 2026
4df667e9-a743-4341-a12b-40af5b476730
Related Documents
Container Closure Systems for Human Drugs and Biological Products
Guidance DocumentAugust 13, 2026Center for Drug Evaluation and Research
Scientific Considerations in Demonstrating Biosimilarity to a Reference Product: Updated Recommendations for Assessing the Need for Comparative Efficacy Studies: Draft Guidance for Industry
Guidance DocumentOctober 29, 2025Center for Drug Evaluation and Research
Considerations in Demonstrating Interchangeability With a Reference Product: Update
Guidance DocumentJune 21, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.